Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful inflammation, today announces that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will grant the patent application WO 2016/131098 as US 10,538,487 on 21 January 2020 and EP 3,259,253 on 15 January … [Read more...] about Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Market Intelligence
Footer
Blockchaining
- The Fascinating World of Cryptocurrency
- State of Technology Overview: Blockchaining 2023
- ETHDenver’s #BUIDLathon and Community-Owned Innovation Festival Returns in February 2023
- Corporate leaders should embrace the potential of blockchain technology before it gets used against them
- Asia’s Premier Web3 Conference TOKEN2049 Returns to Singapore in September 2023
OPINT
- North Korea is working to create a nuclear warfighting capability
- China’s proliferation of nuclear and missile-related technologies to other countries
- The United States has been a major supporter of Ukraine’s security
- The Impact of the Middle East on Global Geopolitics
- The Impact of the Belt and Road Initiative on Global Geopolitics